Bud Genius Announces Share Repurchase
September 04 2014 - 8:37AM
Business Wire
Rightsmile, Inc., which is soon to be called Bud Genius, Inc.
(Symbol: RIGH), today announced that its Board of Directors has
signed an agreement resulting in the net repurchase of 1.499
billion shares of its own stock, almost 5% of the company’s
outstanding shares. The repurchased Company shares have already
been paid in full. The company is continuing to consider further
share repurchases.
"We believe repurchasing our shares is a prudent use of our cash
and we are pleased to continue Bud Genius’ commitment of returning
value to shareholders through possible future share repurchases,”
said CEO Angel Stanz, Bud Genius President and CEO. “Following our
buyback, we will lower the company’s authorized shares. Our
successful share repurchase contract shows our continued confidence
in our strategy to generate long-term profitable growth and strong
cash flow, and by this it reflects our commitment to delivering
value to our shareholders."
Repurchases under Bud Genius’ new program may be made in open
market or privately negotiated transactions in compliance with
Securities and Exchange Commission Rule 10b-18, subject to market
conditions, applicable legal requirements, and other relevant
factors. This share repurchase plan does not obligate the company
to acquire any particular amount of common stock, and it may be
suspended at any time at the Company's discretion. The company had
approximately 30 billion shares of Common Stock outstanding as of
September 3, 2014, and will be reporting an approximate 28.5
billion shares as soon as transfers have settled.
About Bud GeniusAn early leader in an industry that many
are speculating will grow, Bud Genius is one of the first
established analytical cannabis laboratories in the United States.
Bud Genius was launched to bring vendors together with doctors,
patients, and dispensaries that require certified products held to
demanding standards. Bud Genius has a vision to expand across the
US and abroad serving as the beacon of quality for medical cannabis
and adult-use marijuana through the formation of regional
laboratories. Certification, data collection, and online reports
are the measure by which the company gains.
For more information please visit:http://www.BudGenius.com
The foregoing press announcement contains forward-looking
statements that can be identified by such terminology such as
"believes," "expects," "potential," "plans," "suggests," "may,"
"should," "could," "intends," or similar expressions. Such
forward-looking statements involve known and unknown risks,
uncertainties and other factors that may cause the actual results
to be materially different from any future results, performance or
achievements expressed or implied by such statements. In
particular, management's expectations could be affected by, among
other things, uncertainties relating to our success in completing
acquisitions, financing our operations, entering into strategic
partnerships, engaging management and other matters disclosed by us
in our public filings from time to time. Forward-looking statements
speak only as to the date they are made. The Company does not
undertake to update forward-looking statements to reflect
circumstances or events that occur after the date the
forward-looking statements are made.
Bud GeniusAngel Stanz, Chief Executive
Officer855-723-3283PR@BudGenius.com
RightSmile (CE) (USOTC:RIGH)
Historical Stock Chart
From Mar 2024 to Apr 2024
RightSmile (CE) (USOTC:RIGH)
Historical Stock Chart
From Apr 2023 to Apr 2024